These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38629165)

  • 1. A prognostic risk model based on lactate metabolism and transport-related lncRNAs for gastric adenocarcinoma.
    Qian Z; Wu F; Feng G; Lin W; Cai X; Wu J; Ke K; Ye Z; Xu G
    Biomarkers; 2024 Jun; 29(4):211-221. PubMed ID: 38629165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic and integrated analysis identifies an lncRNA-miRNA-mRNA interaction mechanism in gastric adenocarcinoma.
    Liao Y; Cao W; Zhang K; Zhou Y; Xu X; Zhao X; Yang X; Wang J; Zhao S; Zhang S; Yang L; Liu D; Tian Y; Wu W
    Genes Genomics; 2021 Jun; 43(6):613-622. PubMed ID: 33779949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
    Hu X; Wu L; Liu B; Chen K
    Front Immunol; 2021; 12():651056. PubMed ID: 34122409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
    Zha Z; Zhang P; Li D; Liu G; Lu L
    Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel prognostic signature in gastric adenocarcinoma.
    Mao R; Wang Z; Zhang Y; Chen Y; Liu Q; Zhang T; Liu Y
    Aging (Albany NY); 2020 Nov; 12(21):22233-22252. PubMed ID: 33188157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.
    Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L
    Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma.
    Jiang W; Xu Z; Huang L; Qin F; Yuan L; Sun Y; Qin J; Deng K; Zheng T; Long X; Li S
    BMC Med Genomics; 2023 Dec; 16(1):330. PubMed ID: 38110999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA.
    Cai Y; Wu S; Jia Y; Pan X; Li C
    J Immunol Res; 2022; 2022():1249290. PubMed ID: 35528617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic thirteen-long non-coding RNAs (IncRNAs) could improve the survival prediction of gastric cancer.
    Zong Z; Li H; Yu ZM; Tang FX; Zhu XJ; Tian HK; Zhou TC; Wang H
    Gastroenterol Hepatol; 2020 Dec; 43(10):598-606. PubMed ID: 32674880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
    Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA Expression Profiling in Advanced Resected Gastric Adenocarcinoma Tissues.
    Dang Y; Lin L; Ouyang X; Zhang F; Chen S; Wang B; Zhang Z; Chen S; Deng L; Wang W; Wang L; Xiao C; Qi Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key long non-coding RNAs in gastric adenocarcinoma.
    Fu T; Ji X; Bu Z; Zhang J; Wu X; Zong X; Fan B; Jia Z; Ji J
    Cancer Biomark; 2020; 27(4):541-553. PubMed ID: 32176636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.